Efficacy and Safety of Cladribine in Combination With CAG in Newly Diagnosed Unfit Patients With AML

NCT04254640 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia
Elderly Patients
Newly Diagnosed

Interventions

DRUG: Cladribine Injection
DRUG: Aclarubicin
DRUG: G-CSF
DRUG: cytarabine

Sponsor

Sun Yat-sen University